Lung Injury, Acute
24
1
1
17
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
2 terminated out of 24 trials
89.5%
+3.0% vs benchmark
4%
1 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (24)
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients
Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery
Lung Atelectasis Improvement Through Positive End Expiratory Pressure During Anesthetic Induction
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO
Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants
Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air
Features of Regional Perfusion of Lung Consolidation
Soluble VE-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass
Serum Level of Calpains Product as a Novel Biomarker of Acute Lung Injury Following Cardiopulmonary Bypass
Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
Tomographic Findings in COVID-19 and Influenza H1N1
Lung Protection Strategy in Open Heart Surgery: Which Tidal Volume is Better 8ml/kg or 6ml/kg
Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients
Lung Protection and Pediatric Cardiac Surgery
a Study Conducted About a New Mode of Ventilation in Laparoscopic Surgeries
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers